Laser Skin Resurfacing — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Laser skin resurfacing is a dermatological and cosmetic procedure that uses concentrated beams of monochromatic light energy to precisely remove damaged outer layers of skin and stimulate neocollagenesis (new collagen synthesis) in the dermis, resulting in improved skin texture, tone, and firmness. Three primary laser categories are used. Ablative lasers — carbon dioxide (CO2, 10,600 nm wavelength) and erbium-doped yttrium aluminium garnet (Er:YAG, 2,940 nm) — physically vaporise the epidermis and upper dermis, delivering the most dramatic results with the longest recovery. CO2 lasers have a superior thermal coagulation effect and produce more dramatic tightening than Er:YAG; Er:YAG removes tissue with less collateral thermal damage, suitable for lighter treatments. Fractional lasers — both ablative (fractionated CO2 or Er:YAG) and non-ablative (Fraxel 1550 nm, 1927 nm) — treat microscopic treatment zones (MTZs) separated by areas of untreated skin that serve as a healing reservoir, dramatically reducing downtime compared to fully ablative resurfacing while maintaining meaningful clinical efficacy. Laser resurfacing is performed by dermatologists and plastic surgeons in accredited facilities and has been in clinical use since the 1990s, with an extensive evidence base across thousands of peer-reviewed publications.

Laser skin resurfacing is indicated for photoageing (UV-induced fine lines, wrinkles, solar lentigines, irregular pigmentation, skin laxity), acne scarring (atrophic scars including icepick, boxcar, and rolling subtypes), surgical or traumatic scars, sebaceous hyperplasia, and enlarged pores. Ideal candidates are Fitzpatrick skin type I–III (fair to medium olive skin), as the thermal energy of laser resurfacing carries significantly greater risk of post-inflammatory hyperpigmentation (PIH) and hypopigmentation in darker skin types (IV–VI). For darker skin types, non-ablative fractional lasers (1550 nm Fraxel, 1927 nm Fraxel Clear+Brilliant) with conservative settings, Nd:YAG (1064 nm) lasers, and radiofrequency microneedling devices present safer alternatives. Absolute contraindications include: active herpes simplex infection (oral antiviral prophylaxis with valaciclovir 500 mg twice daily from 2 days before to 5 days after treatment is mandatory for HSV-seropositive patients); active acne or rosacea flare; isotretinoin use within 6–12 months (impaired wound healing); significant recent sun exposure or tanning; pregnancy; and known keloid-forming tendency. Realistic expectation counselling is essential — laser resurfacing improves but does not completely erase scars or very deep wrinkles.

For ablative CO2 full-face resurfacing, the procedure is performed under IV sedation or general anaesthesia due to significant discomfort. For smaller areas or fractional treatments, topical anaesthetic cream (EMLA applied 60–90 minutes before) combined with tumescent local anaesthesia (lidocaine 0.1% with adrenaline) is sufficient. Eye protection — metal corneal shields or taped goggles — is placed before any periorbital laser work. Skin is cleansed and degreased with isopropyl alcohol. For fully ablative CO2 resurfacing: the laser (UltraPulse CO2 or SmartXide DOT) delivers ultra-short, high-energy pulses that vaporise the epidermis and upper dermis in a systematic pass across the face. First pass ablates the epidermis; second pass on deeper wrinkles and scar areas treats the upper dermis; a final third pass (feathering) blends the treatment zone perimeter. Laser depth is guided by whitish coagulation appearance of the dermis. For fractional non-ablative Fraxel treatment: the laser handpiece is passed systematically across the treatment area, delivering thousands of microscopic thermal columns per square centimetre while sparing surrounding skin. Frequency of passes and density settings determine treatment intensity. Total operative time: 30 minutes (small area non-ablative) to 90 minutes (full-face ablative CO2 with sedation).

The procedure is performed in an appropriately equipped facility by experienced specialist clinicians. Prior to commencement, the patient undergoes pre-procedural assessment including vital signs measurement, review of relevant investigations, and confirmation of informed consent. Intravenous access is established and monitoring equipment including ECG, pulse oximetry, and blood pressure monitoring is applied.

The procedural site is prepared according to aseptic technique standards. Anaesthesia or analgesia is administered as appropriate for the specific procedure and patient needs, ranging from local anaesthesia for minor procedures to regional or general anaesthesia for more complex interventions.

The procedure is performed under direct visualisation or image guidance as appropriate. Key technical steps are executed with attention to anatomical landmarks and patient safety parameters. Haemostasis is achieved and confirmed before completion. Post-procedural assessment includes clinical evaluation of the immediate result, complication surveillance, and documentation of the procedure.

Recovery room monitoring continues until the patient meets defined discharge criteria. Written post-procedural instructions covering activity restrictions, wound care, medication management, and symptoms requiring urgent review are provided before discharge.

Ablative CO2 laser resurfacing remains the single most effective non-surgical treatment for photodamage and facial wrinkles. Published studies consistently demonstrate 50–80% improvement in perioral and periorbital rhytids (wrinkles) from a single full-face CO2 treatment, with results lasting 5 years or longer with good sun protection and maintenance. Collagen remodelling continues for 6–12 months after ablative treatment, with ongoing textural improvement. Fractional CO2 laser achieves 30–50% scar improvement in atrophic acne scars — significantly superior to chemical peels or dermabrasion for this indication. Non-ablative fractional lasers offer 20–30% improvement in photoageing with only 3–5 days of social downtime versus 14–21 days for fully ablative resurfacing, making them practical for working patients. Laser resurfacing simultaneously reduces pore size, surface irregularity, pigmentation, and skin laxity in a single treatment session. In India, fractional CO2 laser sessions cost approximately INR 8,000–30,000 (USD 100–360) per session, compared to USD 1,500–5,000 in the USA — at internationally trained dermatologists equipped with FDA-approved devices at accredited skin clinics.

Prolonged erythema (post-laser redness persisting beyond expected duration) is the most common complaint after ablative resurfacing, affecting 30–40% of patients for 2–3 months; it is managed with camouflage cosmetics and anti-inflammatory topical agents. Post-inflammatory hyperpigmentation (PIH) is the primary risk in darker skin types (Fitzpatrick IV–VI) and occurs in 10–40% after ablative resurfacing in these patients — managed with pre-treatment hydroquinone 4% for 4–6 weeks, and post-treatment with hydroquinone, azelaic acid, and strict SPF 50 sun protection. Permanent hypopigmentation (loss of melanocytes in heavily treated skin) is a known consequence of very aggressive ablative resurfacing, particularly with repeat sessions — appears as a white, waxy appearance of treated skin visible in sun exposure. Herpes simplex reactivation without antiviral prophylaxis occurs in 2–7% of HSV-seropositive patients and must be treated urgently to prevent scarring. Bacterial or fungal infection requires prompt antibiotic or antifungal treatment. Scarring is rare (under 0.5%) in trained hands with appropriate laser parameters but can occur if healing is compromised. Ectropion (lower eyelid retraction) from periorbital ablative resurfacing requires specialist assessment. Milia (small inclusion cysts) form during healing in 10–15% and resolve with gentle exfoliation or electrodesiccation.

After ablative CO2 full-face resurfacing, the skin weeps serum and looks raw for 7–10 days while new epithelium regenerates. Wound care involves gentle dilute acetic acid soaks (1 part white vinegar to 10 parts water) four times daily to prevent crusting and infection, followed by generous application of plain petrolatum (Vaseline) or prescribed ointment. Physical activities, sun exposure, and application of cosmetics are avoided for the first 10–14 days. By day 7–10, the new epidermis is re-established and cosmetics can be applied to conceal the remaining redness. The skin is pink and sensitive for 6–12 weeks before settling to a natural colour. SPF 50+ sunscreen and protective clothing are mandatory for 3–6 months after ablative resurfacing to prevent PIH and protect collagen remodelling. After fractional non-ablative treatment, mild erythema and pin-point bleeding (microscopic exudate) resolve within 2–4 days. Return to work and social activities is possible at 3–5 days with camouflage makeup. Topical hydrating serums and gentle cleansers are used during the healing phase. Regular moisturisation and SPF 50 sun protection begin immediately after the treatment. Maintenance fractional treatments every 6–12 months extend and optimise long-term results. Topical retinoids (tretinoin 0.025–0.05%) resumed 4–6 weeks post-resurfacing maintain collagen stimulation between sessions.